Scientist/Senior Scientist In vivo Immuno-Oncology
Asgard Therapeutics AB, Lund
Omfattning: HeltidVaraktighet: Tillsvidareanställning
Asgard Therapeutics is a spin-off from Lund University, Sweden, aiming to advance cancer immunotherapies by harnessing direct cell fate reprogramming technologies. Our lead program, AT-108, is a adeno
Publicerad 19 apr.
Scientist/Senior Scientist in vitro immuno-oncology, RNA-based therapeutics
Asgard Therapeutics AB, Lund
Omfattning: HeltidVaraktighet: Tillsvidareanställning
Asgard Therapeutics is a spin-off from Lund University, Sweden, aiming to advance cancer immunotherapies by harnessing direct cell fate reprogramming technologies. Our lead program, AT-108, is a adeno
Publicerad 18 apr.
Scientist/Senior Scientist Gene Therapy
Asgard Therapeutics AB, Lund
Omfattning: HeltidVaraktighet: Tillsvidareanställning
Asgard Therapeutics is a spin-off from Lund University, Sweden, aiming to advance cancer immunotherapies by harnessing direct cell fate reprogramming technologies. Our lead program, AT-108, is a adeno
Publicerad 17 apr.
Scientist/Senior Scientist Organoid Immuno-Oncology
Asgard Therapeutics AB, Lund
Omfattning: HeltidVaraktighet: Tillsvidareanställning
Asgard Therapeutics is a spin-off from Lund University, Sweden, aiming to advance cancer immunotherapies by harnessing direct cell fate reprogramming technologies. Our lead program, AT-108, is a adeno
Publicerad 19 apr.